Digestive Diseases and Sciences

, Volume 52, Issue 6, pp 1548–1553 | Cite as

Successful Management of Aspergillus Liver Abscess in a Patient with Necrotizing Fasciitis

  • Josef Rieder
  • Matthias Lechner
  • Cornelia Lass-Floerl
  • Michael Rieger
  • Ingo Lorenz
  • Hildegunde Piza
  • Hugo Bonatti
Case Report


Invasive Aspergillus infections are among the infectious diseases with the highest mortality and mainly cause diseases in immunocompromised hosts [1, 2]. Notably, the organism can also cause severe surgical site infections [3, 4, 5]. As filamentous fungi are airborne pathogens, in most cases pulmonary infection represents the initial manifestation, with subsequent spread to other organs if the infection cannot be controlled at an early stage [6]. Therefore, liver aspergillosis is seen in most cases if the fungus causes disseminated disease. Liver abscesses of other origin are extremely rare [7, 8]. The spread from an intra-abdominal site through the portal vein is even less likely. Open abdominal treatment is a viable option to control severe intra-abdominal infection or pancreatitis and is also indicated in the case of necrotizing fasciitis of the abdominal wall [9]. The vacuum-assisted closure (VAC) system has been shown to be a useful tool in this setting [10]. The...


Aspergillus Liver abscess Caspofungin Voriconazole Necrotizing fasciitis Interventional radiology 


  1. 1.
    Graybill JR, et al. (1990) Fungal infection and their management. Br J Clin Pract 71(Suppl):23–31Google Scholar
  2. 2.
    Paya CV (1993) Fungal infections in solid-organ transplantation. Clin Infect Dis 16(5):677–688PubMedGoogle Scholar
  3. 3.
    Johnson MA, Lyle G, Hanly M, Yeh KA (1998) Aspergillus: a rare primary organism in soft-tissue infections. Am Surg 64(2):122–126PubMedGoogle Scholar
  4. 4.
    Pla MP, Berenguer J, Arzuaga JA, Banares R, Polo JR, Bouza E (1992) Surgical wound infection by Aspergillus fumigatus in liver transplant recipients. Diagn Microbiol Infect Dis 15(8):703–706PubMedCrossRefGoogle Scholar
  5. 5.
    Stiller MJ, Teperman L, Rosenthal SA, Riordan A, Potter J, Shupack JL, Gordon MA (1994) Primary cutaneous infection by Aspergillus ustus in a 62 year old liver transplant recipient. J Am Acad Dermatol 31(2; Pt 2):344–347PubMedGoogle Scholar
  6. 6.
    Doffman SR, Agrawal SG, Brown JS (2005) Invasive pulmonary aspergillosis. Expert Rev Anti Infect Ther 3(4):613–627PubMedCrossRefGoogle Scholar
  7. 7.
    Lee TY, Yang SS, Chen GH, Hwang WL, Lin YH, Hwang JI (2003) Hepatic abscess caused by Aspergillus fumigatus infection following splenectomy and immunosuppressive therapy. J Formos Med Assoc 102(7):501–505PubMedGoogle Scholar
  8. 8.
    Vairani G, Rebeschini R, Barbazza R (1990) Hepatic and subcutaneous abscesses due to aspergillosis. Initial diagnosis of a case by intraoperative fine needle aspiration cytology. Acta Cytol 34(6):891–894PubMedGoogle Scholar
  9. 9.
    Swan MC, Banwell PE (2005) The open abdomen: aetiology, classification and current management strategies. J Wound Care 14(1):7–11PubMedGoogle Scholar
  10. 10.
    Labler L, Keel M, Trentz O (2004) [New application of V.A.C. (vacuum assisted closure) in the abdominal cavity in case of open abdomen therapy]. Zentralbl Chir 129(Suppl 1):S14–S19PubMedGoogle Scholar
  11. 11.
    Weed T, Ratliff C, Drake DB (2004) Quantifying bacterial bioburden during negative pressure wound therapy:does the wound VAC enhance bacterial clearance? Ann Plast Surg 52(3):276–279PubMedCrossRefGoogle Scholar
  12. 12.
    Mousa HA (1997) Aerobic, anaerobic and fungal burn wound infections. J Hosp Infect 37(4):317–323PubMedCrossRefGoogle Scholar
  13. 13.
    Hartemink KJ, Paul MA, Spijkstra JJ, Girbes AR, Polderman KH (2003) Immunoparalysis as a cause for invasive aspergillosis? Intens Care Med 29(11):2068–2071CrossRefGoogle Scholar
  14. 14.
    Gallis HA, et al. (1990) Amphotericin B:30 years of clinical experience. Rev Infect Dis 12:308–329PubMedGoogle Scholar
  15. 15.
    Gothard P, Rogers TR (2004) Voriconazole for serious fungal infections. Int J Clin Pract 58(1):74–80PubMedCrossRefGoogle Scholar
  16. 16.
    Kauffman CA (2004) New antifungal agents. Semin Respir Crit Care Med 25(2):233–239PubMedCrossRefGoogle Scholar
  17. 17.
    Kartsonis NA, Saah AJ, Joy Lipka C, Taylor AF, Sable CA (2005) Salvage therapy with caspofungin for invasive aspergillosis: results from the caspofungin compassionate use study. J Infect 50(3):196–205PubMedCrossRefGoogle Scholar
  18. 18.
    Baddley JW, Pappas PG (2005) Antifungal combination therapy: clinical potential. Drugs 65(11):1461–1480PubMedCrossRefGoogle Scholar
  19. 19.
    Schuster F, Moelter C, Schmid I, Graubner UB, Kammer B, Belohradsky BH, Fuhrer M (2005) Successful antifungal combination therapy with voriconazole and caspofungin. Pediatr Blood Cancer 44(7):682–685PubMedCrossRefGoogle Scholar
  20. 20.
    Young MH, Aronoff DM, Engleberg NC (2005) Necrotizing fasciitis:pathogenesis and treatment. Expert Rev Anti Infect Ther 3(2):279–294PubMedCrossRefGoogle Scholar
  21. 21.
    Stone HH, Cuzzell JZ, Kolb LD, Moskowitz MS, McGowan JE Jr (1979) Aspergillus infection of the burn wound. J Trauma 19(10):765–767PubMedCrossRefGoogle Scholar
  22. 22.
    Dimitrakopoulos I, Lazaridis N, Asimaki A (2005) Craniofacial invasive aspergillosis in an immunocompetent patient: a case report. J Oral Maxillofac Surg 63(6):845–848PubMedCrossRefGoogle Scholar
  23. 23.
    Johnson MA, Lyle G, Hanly M, Yeh KA (1998) Aspergillus :a rare primary organism in soft–tissue infections. Am Surg 64(2):122–126PubMedGoogle Scholar
  24. 24.
    Vandewoude K, Blot S, Benoit D, Depuydt P, Vogelaers D, Colardyn F (2004) Invasive aspergillosis in critically ill patients:analysis of risk factors for acquisition and mortality. Acta Clin Belg 59(5):251–257PubMedGoogle Scholar
  25. 25.
    Meersseman W, Vandecasteele SJ, Wilmer A, Verbeken E, Peetermans WE, Van Wijngaerden E (2004) Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med 170(6):580–581CrossRefGoogle Scholar
  26. 26.
    Yu SC, Ho SS, Lau WY, Yeung DT, Yuen EH, Lee PS, Metreweli C (2004) Treatment of pyogenic liver abscess:prospective randomized comparison of catheter drainage and needle aspiration. Hepatology 39(4):932–938PubMedCrossRefGoogle Scholar
  27. 27.
    Marr KA, Leisenring W (2005) Design issues in studies evaluating diagnostic tests for aspergillosis. Clin Infect Dis 41(Suppl 6):S381–S386PubMedCrossRefGoogle Scholar
  28. 28.
    Lass–Florl C, Gunsilius E, Gastl G, Bonatti H, Freund MC, Gschwendtner A, Kropshofer G, Dierich MP, Petzer A (2004) Diagnosing invasive aspergillosis during antifungal therapy by PCR analysis of blood samples. J Clin Microbiol 42(9):4154–4157PubMedCrossRefGoogle Scholar
  29. 29.
    Lass-Florl C, Gunsilius E, Gastl G, Freund M, Dierich MP, Petzer A (2005) Clinical evaluation of Aspergillus—PCR for detection of invasive aspergillosis in immunosuppressed patients. Mycoses 48(Suppl 1):12–17PubMedCrossRefGoogle Scholar
  30. 30.
    Buchheidt Buchheidt D, Baust C, Skladny H, Baldus M, Bräuninger S, Hehlmann R (2002) Clinical evaluation of a polymerase chain reaction assay to detect Aspergillus species in bronchoalveolar lavage samples of neutropenic patients. Br J Haematol 116:803–811CrossRefGoogle Scholar
  31. 31.
    Ruhnke M, Bohme A, Buchheidt D, Donhuijsen K, Einsele H, Enzensberger R, Glasmacher A, Gumbel H, Heussel CP, Karthaus M, Lambrecht E, Sudhoff T, Szelenyi H (2003) Diagnosis of invasive fungal infections in hematology and oncology—-guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 82(Suppl 2):S141–S148PubMedCrossRefGoogle Scholar
  32. 32.
    Tan YM, Chung AY, Chow PK, Cheow PC, Wong WK, Ooi LL, Soo KC (2005) An appraisal of surgical and percutaneous drainage for pyogenic liver abscesses larger than 5 cm. Ann Surg 241(3):485–490PubMedCrossRefGoogle Scholar
  33. 33.
    Cesaro S, Visintin G (2005) Combination antifungal therapy for invasive aspergillosis. Clin Infect Dis 40(7):1073–1075PubMedCrossRefGoogle Scholar
  34. 34.
    Marr KA, Boeckh M, Carter RA, Kim HW, Corey L (2004) Combination antifungal therapy for invasive aspergillosis. Clin Infect Dis 39(6):797–802PubMedCrossRefGoogle Scholar
  35. 35.
    Kirkpatrick WR, Perea S, Coco BJ, Patterson TF (2002) Efficacy of caspofungin alone and in combination with voriconazole in a guinea pig model of invasive aspergillosis. Antimicrob Agents Chemother 46(8):2564–2568PubMedCrossRefGoogle Scholar
  36. 36.
    Dannaoui E, Lortholary O, Dromer F (2004) In vitro evaluation of double and triple combinations of antifungal drugs against Aspergillus fumigatus and Aspergillus terreus. Antimicrob Agents Chemother 48(3):970–978PubMedCrossRefGoogle Scholar
  37. 37.
    Callister ME, Griffiths MJ, Nicholson AG, Leonard A, Johnson EM, Polkey MI, Kerr JR (2004) A fatal case of disseminated aspergillosis caused by a non-sporulating strain of Aspergillus fumigatus. J Clin Pathol 57(9):991–992PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2007

Authors and Affiliations

  • Josef Rieder
    • 1
  • Matthias Lechner
    • 2
  • Cornelia Lass-Floerl
    • 2
  • Michael Rieger
    • 3
  • Ingo Lorenz
    • 1
  • Hildegunde Piza
    • 4
  • Hugo Bonatti
    • 5
    • 6
  1. 1.Department of Anaesthesiology and Critical Care MedicineMedical UniversityInnsbruckAustria
  2. 2.Department of Hygiene, Microbiology and Social MedicineMedical UniversityInnsbruckAustria
  3. 3.Department of RadiologyMedical UniversityInnsbruckAustria
  4. 4.Department of Plastic and Reconstructive SurgeryMedical UniversityInnsbruckAustria
  5. 5.Department of General and Transplant SurgeryMedical UniversityInnsbruckAustria
  6. 6.Department of SurgeryMayo ClinicJacksonvilleUSA

Personalised recommendations